Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(25)
•••
Comment by smush74on Dec 29, 2014 10:43pm
289 Views
Post# 23270990

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Today

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Today
news is news, I really could care less about the gossip even less the personal attacks.As per Himmler's comments. Myself I rarely buy or sell around this time of year based on no news. To many factors why some might sell.

It is a calculated risk biotecks, most fail others are lucky enough to succeed. My motto if you can't afford to lose the investment then don't buy. Risk/reward, opportunity cost etc... I will wait for news and if there is actual dialogue I may give my two cent.

Good luck Wittman see what 2015 delivers.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities